TACR1 and cancer: Given the role of the axis formed by Substance P (SP) and its preferred receptor neurokinin-1 receptor (NK-1R) in cancer progression and resistance to oncologic treatments, in this review, we evaluate if the repurposing of aprepitant, which is a safe, efficient and marketed NK-1R antagonist, may be of help to overcome resistance to anticancer treatments.